These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11782994)

  • 1. A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy.
    Ho M; Gallardo E; McKenna-Yasek D; De Luna N; Illa I; Brown RH
    Ann Neurol; 2002 Jan; 51(1):129-33. PubMed ID: 11782994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies).
    Anderson LV; Harrison RM; Pogue R; Vafiadaki E; Pollitt C; Davison K; Moss JA; Keers S; Pyle A; Shaw PJ; Mahjneh I; Argov Z; Greenberg CR; Wrogemann K; Bertorini T; Goebel HH; Beckmann JS; Bashir R; Bushby KM
    Neuromuscul Disord; 2000 Dec; 10(8):553-9. PubMed ID: 11053681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positional cloning of the gene for Miyoshi myopathy and limb-girdle muscular dystrophy].
    Aoki M; Arahata K; Brown RH
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1272-5. PubMed ID: 10791095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy.
    Illarioshkin SN; Ivanova-Smolenskaya IA; Greenberg CR; Nylen E; Sukhorukov VS; Poleshchuk VV; Markova ED; Wrogemann K
    Neurology; 2000 Dec; 55(12):1931-3. PubMed ID: 11134403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
    Piccolo F; Moore SA; Ford GC; Campbell KP
    Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new dysferlin gene mutation in two Japanese families with limb-girdle muscular dystrophy 2B and Miyoshi myopathy.
    Ueyama H; Kumamoto T; Nagao S; Masuda T; Horinouchi H; Fujimoto S; Tsuda T
    Neuromuscul Disord; 2001 Mar; 11(2):139-45. PubMed ID: 11257469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.
    Liu J; Aoki M; Illa I; Wu C; Fardeau M; Angelini C; Serrano C; Urtizberea JA; Hentati F; Hamida MB; Bohlega S; Culper EJ; Amato AA; Bossie K; Oeltjen J; Bejaoui K; McKenna-Yasek D; Hosler BA; Schurr E; Arahata K; de Jong PJ; Brown RH
    Nat Genet; 1998 Sep; 20(1):31-6. PubMed ID: 9731526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
    Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
    Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy.
    Matsuda C; Aoki M; Hayashi YK; Ho MF; Arahata K; Brown RH
    Neurology; 1999 Sep; 53(5):1119-22. PubMed ID: 10496277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
    Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
    Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation.
    McNally EM; Ly CT; Rosenmann H; Mitrani Rosenbaum S; Jiang W; Anderson LV; Soffer D; Argov Z
    Am J Med Genet; 2000 Apr; 91(4):305-12. PubMed ID: 10766988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dysferlin deficiency: the cause of limb-girdle muscular dystrophy 2B and Miyoshi myopathy in a Chinese pedigree].
    Sun S; Fan Q; Wu H; Leturcq F; Zhang B; Yu W; Deburgrave N; Liu M; Song Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):128-31. PubMed ID: 15079794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases].
    Ren SC; Yan CZ; Li MX; Liu SP; Wu JL; Zhao YY; Li W; Li DN
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1486-90. PubMed ID: 17785089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysferlin mutations in Japanese Miyoshi myopathy: relationship to phenotype.
    Takahashi T; Aoki M; Tateyama M; Kondo E; Mizuno T; Onodera Y; Takano R; Kawai H; Kamakura K; Mochizuki H; Shizuka-Ikeda M; Nakagawa M; Yoshida Y; Akanuma J; Hoshino K; Saito H; Nishizawa M; Kato S; Saito K; Miyachi T; Yamashita H; Kawai M; Matsumura T; Kuzuhara S; Ibi T; Sahashi K; Nakai H; Kohnosu T; Nonaka I; Arahata K; Brown RH; Saito H; Itoyama Y
    Neurology; 2003 Jun; 60(11):1799-804. PubMed ID: 12796534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
    Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
    Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysferlin is a plasma membrane protein and is expressed early in human development.
    Anderson LV; Davison K; Moss JA; Young C; Cullen MJ; Walsh J; Johnson MA; Bashir R; Britton S; Keers S; Argov Z; Mahjneh I; Fougerousse F; Beckmann JS; Bushby KM
    Hum Mol Genet; 1999 May; 8(5):855-61. PubMed ID: 10196375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.
    Leriche-Guérin K; Anderson LV; Wrogemann K; Roy B; Goulet M; Tremblay JP
    Neuromuscul Disord; 2002 Feb; 12(2):167-73. PubMed ID: 11738359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency.
    Prelle A; Sciacco M; Tancredi L; Fagiolari G; Comi GP; Ciscato P; Serafini M; Fortunato F; Zecca C; Gallanti A; Chiveri L; Bresolin N; Scarlato G; Moggio M
    Acta Neuropathol; 2003 Jun; 105(6):537-42. PubMed ID: 12734659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.